Vantage logo

Destiny’s date with a partner

The UK company insists that by the end of the year a partner will have been found for its microbiome project to prevent C difficile infections.

Vantage logo

Biopharma buyouts still pricey

A global pandemic has done nothing to crimp M&A premiums, with acquirers forced to swallow ever higher price tags.